Effects of Fesoterodine, a Novel Antimuscarinic, Alone and in Combination with an α-Receptor Blocker, Doxazosin, on Bladder Function in Obstructed Rats

    March 2009 in “ The Journal of Urology
    Claudius Füllhase, Roberto Soler, Marina Brodsky … Karl‐Erik Andersson
    Studysummary This review discusses trials on therapies for benign prostatic hyperplasia and reports that combination treatment is more effective than monotherapy for symptom relief and slowing disease progression in men with moderate to severe symptoms and enlarged prostate glands.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Related research 2

    1. The Impact of COVID-19 on the Menstrual Cycle: A General Perspective Brazilian Journal of Health Review · 2023
    2. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003